Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer

Post time 2024-5-21 20:34:13

journal：Journal of Medicinal Chemistry

Authors：Tizhi Wu; Bin Yu; Yifan Xu; Zekun Du; Zhiming Zhang; Yuxiao Wang; Haoming Chen; Li′ao Zhang; Rui Chen; Feihai Ma; Weihong Gong; Sixian Yu; Zhixia Qiu; Hongxi Wu; Xi Xu; Jubo Wang; Zhiyu Li; Jinlei Bian

Published date：2023-11-23

DOI：10.1021/acs.jmedchem.3c01400

PDF link：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c01400

Article link：http://dx.doi.org/10.1021/acs.jmedchem.3c01400

Article Source：American Chemical Society (ACS)。

Remark：

Post time 2024-5-21 20:34:14

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-5-23 03:04:41

: This post has been completed
Completed attachments will be deleted within 24 hours.

[ACS] Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today